腹腔镜与开腹手术治疗临床II/III期胃癌的长期结局:日本多中心队列研究
该多中心历史性队列研究纳入2008至2014年8家医院共1948例临床II/III期胃腺癌胃切除术患者,经倾向性评分匹配后比较610例(开腹组305例、腹腔镜组305例)的长期结局。结果显示两组5年总生存率分别为53.0%和54.2%,总生存风险比(腹腔镜/开腹)为1.01(95%CI 0.80-1.29),腹腔镜组的非劣效性得到统计学证明。
要点
- 倾向性评分匹配后腹腔镜与开腹组5年总生存率分别为54.2%与53.0%,总生存风险比1.01(95%CI 0.80-1.29)。
- 腹腔镜组复发率为29.8%,开腹组为30.8%,复发风险比0.98(95%CI 0.74-1.31)。
- 两组复发模式相似,提示腹腔镜用于局部进展期胃癌肿瘤学结局与开腹相当。
核心结论
- 该严格校正混杂因素的观察性研究提示,对于局部进展期胃癌,腹腔镜胃切除术的肿瘤学结局与开腹胃切除术相当。
研究设计与样本
- 多中心历史性队列研究,通过共识会议确定30个术前变量以估计倾向性评分。
- 共纳入2008至2014年8家医院1948例连续胃腺癌(临床II/III期)胃切除术患者,倾向性评分匹配后610例(开腹组305例、腹腔镜组305例)用于比较长期结局。
主要发现
- 匹配后开腹组与腹腔镜组平均观察期分别为3.5年和3.4年。
- 5年总生存率开腹组为53.0%,腹腔镜组为54.2%。
- 总生存风险比(腹腔镜/开腹)为1.01(95%CI 0.80-1.29),因95%CI上限小于预设界值1.33,腹腔镜非劣效性得到统计学证明。
- 复发率开腹组为30.8%,腹腔镜组为29.8%,复发风险比为0.98(95%CI 0.74-1.31)。
- 两组复发模式相似。
关键数值与推荐
- 非劣效性界值预设为1.33,总生存风险比95%CI上限0.80-1.29小于该界值。
临床怎么用
- 对于临床II/III期胃癌,腹腔镜胃切除术可作为与开腹手术肿瘤学结局相当的选项,但需结合正在进行的随机试验结果进一步验证。
局限性
- 本研究为观察性历史性队列研究,非随机对照设计。
- 腹腔镜用于进展期胃癌的适用性仍需等待正在进行的随机试验结果验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: A large-scale multicenter historical cohort study was conducted to investigate the efficacy of laparoscopic gastrectomy (LG) in comparison to open gastrectomy (OG) for locally advanced gastric cancer. BACKGROUND: LG is now practiced widely, but its applicability for advanced gastric cancer is still controversial. As oncologic outcomes of randomized trials are still pending, there is an urgent need for information that would be relevant to current practice. METHODS: Through a consensus meeting involving surgeons and biostatisticians, 30 preoperative variables possibly influencing the choice of surgical approach and associated with outcome were identified to enable rigorous estimation of propensity scores. A total of 1948 consecutive patients who underwent gastrectomy for clinical stage II/III gastric adenocarcinoma between 2008 and 2014 were identified, and their clinical data were collected from 8 participating hospitals. After propensity score matching, 610 cases (OG = 305, LG = 305) were finally selected for comparison of long-term outcomes. RESULTS: In the propensity-matched OG and LG populations, the mean observation period was 3.5 and 3.4 years, and the 5-year overall survival was 53.0% and 54.2%, respectively. The hazard ratio (LG/OG) for overall survival was 1.01 (95% confidence interval, 0.80-1.29), and noninferiority of LG was demonstrated statistically as the upper 95% confidence limit was less than the prespecified margin (1.33). The recurrence rate was 30.8% and 29.8% for OG and LG, respectively, and the hazard ratio for recurrence was 0.98 (95% confidence interval, 0.74-1.31). The patterns of recurrence in the 2 groups were similar. CONCLUSIONS: This observational study strictly adjusted for confounding factors has provided evidence to suggest that LG is oncologically comparable to OG for locally advanced gastric cancer. The validity of this result will be examined in ongoing randomized trials.
引用
- Kinoshita T, Uyama I, Terashima M, et al. Long-term Outcomes of Laparoscopic Versus Open Surgery for Clinical Stage II/III Gastric Cancer: A Multicenter Cohort Study in Japan (LOC-A Study). Ann Surg. 2019. PMID: 29697447. doi:10.1097/SLA.0000000000002768
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。